Published in J Infect Dis on November 01, 2011
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J Infect Dis (2011) 1.82
Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick. JAMA (2015) 1.64
Emerging targets and novel approaches to Ebola virus prophylaxis and treatment. BioDrugs (2013) 1.57
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis (2012) 1.32
Current ebola vaccines. Expert Opin Biol Ther (2012) 1.30
Ebolavirus in West Africa, and the use of experimental therapies or vaccines. BMC Biol (2014) 1.19
Biologically hazardous agents at work and efforts to protect workers' health: a review of recent reports. Saf Health Work (2014) 1.17
Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries. PLoS One (2014) 1.16
Development of replication-competent viral vectors for HIV vaccine delivery. Curr Opin HIV AIDS (2013) 0.96
Potential vaccines and post-exposure treatments for filovirus infections. Viruses (2012) 0.94
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin Microbiol Rev (2015) 0.92
Medical research: Ebola therapy protects severely ill monkeys. Nature (2014) 0.91
Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates. PLoS One (2014) 0.88
Ebola virus infection: what should be known? N Am J Med Sci (2014) 0.87
Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials. PLoS Pathog (2013) 0.87
Novel vaccine strategies against emerging viruses. Curr Opin Virol (2013) 0.81
A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine. J Virol (2014) 0.81
Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona. J Infect Dis (2016) 0.80
Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers. J Vaccines Vaccin (2012) 0.79
Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med Microbiol Immunol (2015) 0.79
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? Philos Trans R Soc Lond B Biol Sci (2017) 0.79
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. Eur J Clin Microbiol Infect Dis (2016) 0.79
Ebola and Its Global Research Architecture-Need for an Improvement. PLoS Negl Trop Dis (2015) 0.78
Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep (2016) 0.77
Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations. J Clin Microbiol (2015) 0.77
Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic. Sci Rep (2016) 0.77
A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact. Expert Rev Anti Infect Ther (2015) 0.76
Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus. Clin Infect Dis (2016) 0.76
Biosecurity measures in 48 isolation facilities managing highly infectious diseases. Biosecur Bioterror (2012) 0.75
Biosafety and Biosecurity: A Relative Risk-Based Framework for Safer, More Secure, and Sustainable Laboratory Capacity Building. Front Public Health (2015) 0.75
Ebola hemorrhagic fever: current outbreak and progress in finding a cure. Daru (2014) 0.75
A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus. Front Immunol (2017) 0.75
A dead-end host: is there a way out? A position piece on the ebola virus outbreak by the international union of immunology societies. Front Immunol (2014) 0.75
Epidemiology of ebolavirus disease (EVD) and occupational EVD in health care workers in Sub-Saharan Africa: Need for strengthened public health preparedness. J Epidemiol (2017) 0.75
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
Ebola haemorrhagic fever. Lancet (2011) 8.28
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis (2007) 6.46
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature (2003) 6.35
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Viral discovery and sequence recovery using DNA microarrays. PLoS Biol (2003) 5.95
Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92
Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol (2004) 5.86
Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med (2014) 5.74
Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis (2004) 5.49
Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49
Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med (2004) 4.89
Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog (2009) 4.88
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67
A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet (2010) 4.52
A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med (2012) 4.15
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05
Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis (2003) 4.02
Marburg virus infection detected in a common African bat. PLoS One (2007) 4.01
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis (2007) 3.74
Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69
Discovery of swine as a host for the Reston ebolavirus. Science (2009) 3.68
Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis (2006) 3.65
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet (2003) 3.57
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol (2006) 3.50
Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio (2014) 3.49
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38
An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis (2002) 3.36
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis (2003) 3.33
Rift Valley fever virus. J Am Vet Med Assoc (2009) 3.22
Bat Nipah virus, Thailand. Emerg Infect Dis (2005) 3.22
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol (2004) 3.04
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Syndromic surveillance and bioterrorism-related epidemics. Emerg Infect Dis (2003) 3.00
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99